坐骨神経痛の世界市場レポート 2025年

坐骨神経痛の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.6％で91億4,000万米ドルに成長します。予測期間の成長は、個別化医療、遠隔医療と遠隔処置、患者教育と意識向上、償還政策に起因すると考えられます。予測期間の主な動向には、高度画像診断、再生医療、デジタル治療、予防対策などがあります。

整形外科手術の増加は、今後の坐骨神経痛市場の成長を牽引すると予想されます。脊椎、関節、骨格系に影響を及ぼす状態に対処する整形外科処置は、高齢化、筋骨格系障害の有病率の上昇、身体活動やスポーツへの参加の増加などの要因により増加傾向にあります。坐骨神経に沿った痛みを引き起こす坐骨神経痛は、痛みを和らげ、可動性を回復させ、生活の質を向上させるために、整形外科医や外科医による治療が必要となることが多くあります。例えば、国立医学図書館が2023年2月に発表した研究では、人工股関節全置換術（THA）と人工膝関節全置換術（TKA）の手術件数は2040年までに大幅に増加し、THA手術件数は71万9,364件、TKA手術件数は122万2,988件増加すると予測しています。2060年までには、TKAは291万7,959件、THAは198万2,099件に達すると予想されます。このような整形外科手術の増加に伴い、坐骨神経痛に関連する治療や療法に対する需要も増加し、市場の成長が予想されます。

腰痛の有病率の増加は、坐骨神経痛市場の成長を促進すると予想されます。腰痛とは、背骨、椎間板、筋肉、靭帯、腱における様々な機械的または構造的な問題、および背中の神経圧迫を指します。腰痛がある人は、坐骨神経に沿った痛みを特徴とする坐骨神経痛を発症する高いリスクがあります。腰痛の問題が一般的になるにつれ、坐骨神経痛の痛みを和らげる治療や解決策への需要が高まっています。例えば、シドニー大学が2023年5月に行った研究では、30年以上にわたるデータを分析し、腰痛の症例数が増加傾向にあることがわかりました。予測では、2050年までに8億4,300万人が腰痛に悩まされると予測されていますが、これは人口増加と高齢化が主な原因です。このような腰痛の有病率の増加が坐骨神経痛治療に対する需要を促進し、市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の坐骨神経痛市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の坐骨神経痛市場：成長率分析
• 世界の坐骨神経痛市場の実績：規模と成長、2019～2024年
• 世界の坐骨神経痛市場の予測：規模と成長、2024～2029年、2034年
• 世界の坐骨神経痛総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の坐骨神経痛市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 急性坐骨神経痛
• 慢性坐骨神経痛
• その他
• 世界の坐骨神経痛市場：薬物タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• オキシコドン
• トラマドール
• オピオイド鎮痛剤
• アミトリプチリン
• 三環系抗うつ薬
• その他
• 世界の坐骨神経痛市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬剤
• 手術
• 世界の坐骨神経痛市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• ホームケア
• 専門クリニック
• その他
• 世界の坐骨神経痛市場：急性坐骨神経痛のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 短期疼痛管理
• 理学療法
• 非ステロイド性抗炎症薬（NSAID）
• 世界の坐骨神経痛市場：慢性坐骨神経痛のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 長期疼痛管理
• 硬膜外ステロイド注射
• 外科的治療
• 世界の坐骨神経痛市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 椎間板ヘルニアによる坐骨神経痛
• 脊柱管狭窄症による坐骨神経痛
• 脊椎すべり症による坐骨神経痛

第7章 地域別・国別分析

• 世界の坐骨神経痛市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の坐骨神経痛市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 坐骨神経痛市場：競合情勢
• 坐骨神経痛市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi-Aventis LLC.
• AstraZeneca PLC
• GlaxoSmithKline plc.
• Eli Lilly and Co Ltd.
• Boehringer Ingelheim International GmbH
• Teva Pharmaceutical Industries Ltd.
• Macleods Pharmaceuticals Limited
• Sun Pharmaceutical Industries Limited
• Dr. Reddy's Laboratories Ltd.
• Aurobindo Pharma Ltd.
• Intas Pharmaceuticals Ltd.
• Hikma Pharmaceuticals PLC
• Cipla Inc.
• Endo International plc
• Amneal Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 坐骨神経痛市場2029：新たな機会を提供する国
• 坐骨神経痛市場2029：新たな機会を提供するセグメント
• 坐骨神経痛市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Sciatica is characterized by pain resulting from inflammation, irritation, or compression of the sciatic nerve, typically occurring in the leg due to pressure or injury. Physical therapy proves effective in alleviating sciatica by enhancing flexibility, strength, and range of motion, thereby reducing pressure on the affected nerve.

There are several types of sciatica, including acute and chronic sciatica. Acute sciatica is characterized by lower back pain that can last for up to six weeks and is typically caused by pressure or injury to the sciatic nerve. Treatment options for sciatica encompass a variety of drugs such as oxycodone, tramadol, opioid analgesics, amitriptyline, tricyclic antidepressants, among others. Additionally, treatments may involve medication regimens and surgical interventions, catering to a diverse range of end-users including hospitals, homecare, specialty clinics, and other healthcare facilities.

The sciatica market research report is one of a series of new reports from The Business Research Company that provides sciatica market statistics, including sciatica industry global market size, regional shares, competitors with a sciatica market share, detailed sciatica market segments, market trends and opportunities and any further data you may need to thrive in the sciatica industry. This sciatica market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sciatica market size has grown strongly in recent years. It will grow from $6.93 billion in 2024 to $7.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to innovative pain management solutions, digital health, telemedicine, personalized treatment approaches, integrative care models.

The sciatica market size is expected to see strong growth in the next few years. It will grow to $9.14 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to personalized medicine, telemedicine and remote procedures, patient education and awareness, reimbursement policies. Major trends in the forecast period include advanced diagnostic imaging, regenerative medicine, digital therapeutics, preventive measures.

The increasing number of orthopedic procedures is expected to drive the growth of the sciatica market going forward. Orthopedic procedures, which address conditions affecting the spine, joints, and skeletal system, are on the rise due to factors such as an aging population, a higher prevalence of musculoskeletal disorders, and growing participation in physical activities and sports. Sciatica, which causes pain along the sciatic nerve, often requires treatment that can involve orthopedic doctors and surgeons to alleviate pain, restore mobility, and improve quality of life. For example, a February 2023 study published by the National Library of Medicine forecasted that total hip arthroplasty (THA) and total knee arthroplasty (TKA) procedures would increase significantly by 2040, with THA procedures growing by 719,364 and TKA procedures rising by 1,222,988. By 2060, the number of TKAs is expected to reach 2,917,959, while THAs will total 1,982,099. As orthopedic surgeries increase, so too will the demand for treatments and therapies related to sciatica, fueling market growth.

The growing prevalence of back problems is expected to propel the growth of the sciatica market. Back problems refer to various mechanical or structural issues in the spine, discs, muscles, ligaments, or tendons, as well as nerve compression in the back. Individuals with back issues are at higher risk of developing sciatica, a condition characterized by pain along the sciatic nerve. As back problems become more common, there is an increased demand for treatments and solutions to alleviate sciatica pain. For example, a study conducted by the University of Sydney in May 2023 analyzed over 30 years of data and found that the number of cases of low back pain is on the rise. Projections indicate that by 2050, 843 million people will be affected by low back pain, largely due to population growth and aging. This growing prevalence of back problems is driving the demand for sciatica treatments, fueling the market's expansion.

Prominent companies in the sciatica market are actively engaged in the development and approval of innovative products in collaboration with federal agencies, as a strategic move to maintain their market standing. These advancements in sciatica therapy not only offer improved treatment options but also serve to mitigate side effects, enhance overall efficacy, and broaden the spectrum of available treatments. For instance, in June 2022, SciatiEase Labs, a US-based health supplement company, achieved approval for its product "SciatiEase" from the United States Food and Drug Administration (FDA), a federal agency in the United States. SciatiEase is a powerful supplement that amalgamates various beneficial elements into a single pill, designed to alleviate sporadic discomfort associated with sciatic nerve pain. These supplements are specifically crafted for individuals who regularly grapple with discomfort along the sciatic nerve and may face dietary restrictions that hinder their ability to naturally alleviate such discomfort.

In April 2023, Nura Pain Clinics, a US-based medical practice clinic, merged with Capitol Pain Institute Inc. for an undisclosed amount. This merger is poised to deliver an innovative and integrated approach to care, all while maintaining their shared commitment to aiding individuals enduring chronic pain. Capitol Pain Institute Inc., an American clinic specializing in interventional pain care, caters to a range of conditions, including sciatica and back pain.

Major companies operating in the sciatica market are Pfizer Inc., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Macleods Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Intas Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., Lupin Limited, Alkem Laboratories Limited, Torrent Pharmaceuticals Ltd.

North America was the largest region in the sciatica market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sciatica report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sciatica market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sciatica market consists of revenues earned by entities by providing services such as medication and heat therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The sciatica market also includes sales of muscle relaxants, which are used in providing services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sciatica Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sciatica market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sciatica ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sciatica market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Acute Sciatica; Chronic Sciatica; Other Types
• 2) By Drugs: Oxycodone; Tramadol; Opioid Analgesics; Amitriptyline; Tricyclic Antidepressants; Other Drugs
• 3) By Treatment: Medication; Surgery
• 4) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Acute Sciatica: Short-Term Pain Management; Physical Therapy; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• 2) By Chronic Sciatica: Long-Term Pain Management; Epidural Steroid Injections; Surgical Options
• 3) By Other Types: Sciatica Due To Herniated Disc; Sciatica From Spinal Stenosis; Sciatica From Spondylolisthesis
• Companies Mentioned: Pfizer Inc.; Merck and Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sciatica Market Characteristics

3. Sciatica Market Trends And Strategies

4. Sciatica Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Sciatica Growth Analysis And Strategic Analysis Framework

• 5.1. Global Sciatica PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Sciatica Market Growth Rate Analysis
• 5.4. Global Sciatica Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Sciatica Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Sciatica Total Addressable Market (TAM)

6. Sciatica Market Segmentation

• 6.1. Global Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Sciatica
• Chronic Sciatica
• Other Types
• 6.2. Global Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxycodone
• Tramadol
• Opioid Analgesics
• Amitriptyline
• Tricyclic Antidepressants
• Other Drugs
• 6.3. Global Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• 6.4. Global Sciatica Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Sciatica Market, Sub-Segmentation Of Acute Sciatica, By type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short-Term Pain Management
• Physical Therapy
• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
• 6.6. Global Sciatica Market, Sub-Segmentation Of Chronic Sciatica, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long-Term Pain Management
• Epidural Steroid Injections
• Surgical Options
• 6.7. Global Sciatica Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sciatica Due To Herniated Disc
• Sciatica From Spinal Stenosis
• Sciatica From Spondylolisthesis

7. Sciatica Market Regional And Country Analysis

• 7.1. Global Sciatica Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Sciatica Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sciatica Market

• 8.1. Asia-Pacific Sciatica Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sciatica Market

• 9.1. China Sciatica Market Overview
• 9.2. China Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sciatica Market

• 10.1. India Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sciatica Market

• 11.1. Japan Sciatica Market Overview
• 11.2. Japan Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sciatica Market

• 12.1. Australia Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sciatica Market

• 13.1. Indonesia Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sciatica Market

• 14.1. South Korea Sciatica Market Overview
• 14.2. South Korea Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sciatica Market

• 15.1. Western Europe Sciatica Market Overview
• 15.2. Western Europe Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sciatica Market

• 16.1. UK Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sciatica Market

• 17.1. Germany Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sciatica Market

• 18.1. France Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sciatica Market

• 19.1. Italy Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sciatica Market

• 20.1. Spain Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sciatica Market

• 21.1. Eastern Europe Sciatica Market Overview
• 21.2. Eastern Europe Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sciatica Market

• 22.1. Russia Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sciatica Market

• 23.1. North America Sciatica Market Overview
• 23.2. North America Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sciatica Market

• 24.1. USA Sciatica Market Overview
• 24.2. USA Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sciatica Market

• 25.1. Canada Sciatica Market Overview
• 25.2. Canada Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sciatica Market

• 26.1. South America Sciatica Market Overview
• 26.2. South America Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sciatica Market

• 27.1. Brazil Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sciatica Market

• 28.1. Middle East Sciatica Market Overview
• 28.2. Middle East Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sciatica Market

• 29.1. Africa Sciatica Market Overview
• 29.2. Africa Sciatica Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Sciatica Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Sciatica Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sciatica Market Competitive Landscape And Company Profiles

• 30.1. Sciatica Market Competitive Landscape
• 30.2. Sciatica Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Sciatica Market Other Major And Innovative Companies

• 31.1. Sanofi-Aventis LLC.
• 31.2. AstraZeneca PLC
• 31.3. GlaxoSmithKline plc.
• 31.4. Eli Lilly and Co Ltd.
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Teva Pharmaceutical Industries Ltd.
• 31.7. Macleods Pharmaceuticals Limited
• 31.8. Sun Pharmaceutical Industries Limited
• 31.9. Dr. Reddy's Laboratories Ltd.
• 31.10. Aurobindo Pharma Ltd.
• 31.11. Intas Pharmaceuticals Ltd.
• 31.12. Hikma Pharmaceuticals PLC
• 31.13. Cipla Inc.
• 31.14. Endo International plc
• 31.15. Amneal Pharmaceuticals Inc.

32. Global Sciatica Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sciatica Market

34. Recent Developments In The Sciatica Market

35. Sciatica Market High Potential Countries, Segments and Strategies

• 35.1 Sciatica Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Sciatica Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Sciatica Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer